| Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis P Nagy, J Claus, TM Jovin, DJ Arndt-Jovin Proceedings of the National Academy of Sciences 107 (38), 16524-16529, 2010 | 199 | 2010 |
| Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface J Claus, G Patel, F Autore, A Colomba, G Weitsman, TN Soliman, ... Elife 7, e32271, 2018 | 65 | 2018 |
| An oncogenic phenoscape of colonic stem cell polarization X Qin, FC Rodriguez, J Sufi, P Vlckova, J Claus, CJ Tape Cell 186 (25), 5554-5568. e18, 2023 | 48 | 2023 |
| Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses MR Zapatero, A Tong, JW Opzoomer, R O’Sullivan, FC Rodriguez, J Sufi, ... Cell 186 (25), 5606-5619. e24, 2023 | 35 | 2023 |
| Update on imatinib for gastrointestinal stromal tumors: duration of treatment M Linch, J Claus, C Benson OncoTargets and therapy, 1011-1023, 2013 | 35 | 2013 |
| A role for the pseudokinase HER3 in the acquired resistance against EGFR-and HER2-directed targeted therapy J Claus, G Patel, T Ng, PJ Parker Biochemical Society Transactions 42 (4), 831-836, 2014 | 29 | 2014 |
| Targeting protein kinase C in sarcoma J Martin-Liberal, AJ Cameron, J Claus, IR Judson, PJ Parker, M Linch Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 547-559, 2014 | 17 | 2014 |
| Cluster analysis of endogenous HER2 and HER3 receptors in SKBR3 cells SK Roberts, M Hirsch, A McStea, LC Zanetti-Domingues, DT Clarke, ... Bio-protocol 8 (23), e3096-e3096, 2018 | 16 | 2018 |
| Pseudokinase drug intervention: a potentially poisoned chalice J Claus, AJM Cameron, PJ Parker Biochemical Society Transactions 41 (4), 1083-1088, 2013 | 15 | 2013 |
| A small molecule inhibitor of HER3: a proof-of-concept study A Colomba, M Fitzek, R George, G Weitsman, S Roberts, ... Biochemical Journal 477 (17), 3329-3347, 2020 | 11 | 2020 |
| F., Colomba, A., Weitsman, G., Soliman, TN et al.(2018) Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface J Claus, G Patel Elife 7, e32271, 0 | 11 | |
| Regulation of the cytokinesis cleavage furrow by PKCε N Brownlow, T Pike, V Crossland, J Claus, P Parker Biochemical Society Transactions 42 (6), 1534-1537, 2014 | 9 | 2014 |
| Functional implications of assigned, assumed and assembled PKC structures M Linch, P Riou, J Claus, AJ Cameron, J de Naurois, B Larijani, T Ng, ... Biochemical Society Transactions 42 (1), 35-41, 2014 | 8 | 2014 |
| A single-cell perturbation landscape of colonic stem cell polarisation X Qin, FC Rodriguez, J Sufi, P Vlckova, J Claus, CJ Tape bioRxiv, 2023.02. 15.528008, 2023 | 7 | 2023 |
| Proteolethargy is a pathogenic mechanism in chronic disease A Dall’Agnese, MM Zheng, S Moreno, JM Platt, AT Hoang, D Kannan, ... Cell 188 (1), 207-221. e30, 2025 | 5 | 2025 |
| Targeting the HER3 pseudokinase domain with small molecule inhibitors A Colomba, J Claus, F Gao, R George, A Fornili, AJM Cameron Methods in Enzymology 667, 455-505, 2022 | 2 | 2022 |
| Long-term in vitro expansion of a human fetal pancreas stem cell that generates all three pancreatic cell lineages A Andersson-Rolf, K Groot, J Korving, H Begthel, MAJ Hanegraaf, ... Cell 187 (26), 7394-7413. e22, 2024 | 1 | 2024 |
| The pseudokinase HER3: Structure/function relationships and inhibitor-induced signalling J Claus UCL (University College London), 2014 | | 2014 |
